CRF Connect Logo
  • Tracks & Learning Series
    VIEW ALL
  • Conferences
  • My Favorites

Coronary

Devices and Complications Learning Series

DES and BRS

Coronary >
DES and BRS

Episodes

Novel Solutions for High Bleeding Risk Patients

Novel Solutions for High Bleeding Risk Patients

18 min.

Does Polymer Coating Matter? Biodegradable vs Durable vs Polymer-Free

Does Polymer Coating Matter? Biodegradable vs Durable vs Polymer-Free

9 min.

DES to Allow Adaptive Remodeling

DES to Allow Adaptive Remodeling

19 min.

The Modern Era of Ultra-Thin Struts – Is It a True Advantage?

The Modern Era of Ultra-Thin Struts – Is It a True Advantage?

9 min.

The Future of Combined Technology – DES Plus DCB

The Future of Combined Technology – DES Plus DCB

12 min.

Recurrent Revascularization After Treatment Of Drug-Eluting Stent Restenosis With Drug-Coated Balloon, Plain Balloon Or Drug-Eluting Stent  10-Year Results From the Randomized ISAR-DESIRE 3 Trial

Recurrent Revascularization After Treatment Of Drug-Eluting Stent Restenosis With Drug-Coated Balloon, Plain Balloon Or Drug-Eluting Stent 10-Year Results From the Randomized ISAR-DESIRE 3 Trial

15 min.

Dedicated Bifurcation Stents: Why Did They Disappear, and What’s on the Horizon?

Dedicated Bifurcation Stents: Why Did They Disappear, and What’s on the Horizon?

17 min.

Long-Term Outcomes with Biodegradable Polymer Sirolimus-Eluting Stents Versus Durable Polymer Everolimus-Eluting Stents in Patients With ST-Segment Elevation Myocardial Infarction: 5-Year Follow-up of the Biostemi Randomized Trial

Long-Term Outcomes with Biodegradable Polymer Sirolimus-Eluting Stents Versus Durable Polymer Everolimus-Eluting Stents in Patients With ST-Segment Elevation Myocardial Infarction: 5-Year Follow-up of the Biostemi Randomized Trial

24 min.

Polymer-Free Amphilimus-Eluting Stents vs. Biodegradable-Polymer Everolimus-Eluting Stents in All-Comers Undergoing PCI: 1-Year Results of the PARTHENOPE Trial

Polymer-Free Amphilimus-Eluting Stents vs. Biodegradable-Polymer Everolimus-Eluting Stents in All-Comers Undergoing PCI: 1-Year Results of the PARTHENOPE Trial

14 min.

The Primary Endpoint Results from the COMPARE 60/80 HBR Trial: A Randomized Controlled Multi-Center Trial Comparing Ultrathin With Thin Strut Stents in High Bleeding Risk Patients With an Abbreviated DAPT Duration

The Primary Endpoint Results from the COMPARE 60/80 HBR Trial: A Randomized Controlled Multi-Center Trial Comparing Ultrathin With Thin Strut Stents in High Bleeding Risk Patients With an Abbreviated DAPT Duration

18 min.

First Human Use of a ‘Hybrid’ (Polymer + Metal) Coronary Drug-Eluting Stent: The IonMAN Study

First Human Use of a ‘Hybrid’ (Polymer + Metal) Coronary Drug-Eluting Stent: The IonMAN Study

11 min.

A Randomized Clinical Trial of a Novel Triple Drug Eluting Coronary Implant Eluting Two Anticoagulants and Sirolimus: Six-Month Clinical and Imaging Results of the DESyne BDS Plus Study

A Randomized Clinical Trial of a Novel Triple Drug Eluting Coronary Implant Eluting Two Anticoagulants and Sirolimus: Six-Month Clinical and Imaging Results of the DESyne BDS Plus Study

13 min.

Yes: There Is Always Room For Better Stents

Yes: There Is Always Room For Better Stents

24 min.

No: Current DES Are Better Than Ever

No: Current DES Are Better Than Ever

6 min.

MeRes Thin-Strut Sirolimus-eluting BRS

MeRes Thin-Strut Sirolimus-eluting BRS

7 min.

Cre8 Amphilimus: Polymer-Free Drug-Eluting Coronary  Stent

Cre8 Amphilimus: Polymer-Free Drug-Eluting Coronary Stent

8 min.

Abluminus Hybrid DES+DCB Technology

Abluminus Hybrid DES+DCB Technology

6 min.

Ionir Ultrathin Polymer Mesh Coronary DES

Ionir Ultrathin Polymer Mesh Coronary DES

6 min.

DESyne BDS Plus: Triple Drug Coronary Stent Eluting Two anticoagulants and Sirolimus

DESyne BDS Plus: Triple Drug Coronary Stent Eluting Two anticoagulants and Sirolimus

5 min.

Dynamx Bioadaptor Coronary Stent Technology Designed to Restore Vasomotion

Dynamx Bioadaptor Coronary Stent Technology Designed to Restore Vasomotion

7 min.

Does It Matter What Stent I Use in a HBR Patient?

Does It Matter What Stent I Use in a HBR Patient?

8 min.

DynamX Bioadaptor and Desyne BDS+

DynamX Bioadaptor and Desyne BDS+

6 min.

IoNir Hybrid Coronary DES System

IoNir Hybrid Coronary DES System

6 min.

Safety and Performance of a Sirolimus Eluting Resorbable Coronary Magnesium Scaffold (DREAMS 3G): The BIOMAG-1 FIH Trial

Safety and Performance of a Sirolimus Eluting Resorbable Coronary Magnesium Scaffold (DREAMS 3G): The BIOMAG-1 FIH Trial

7 min.

Rotablation and Cutting Balloon to Release Stuck Externalized RG3 in an Ostial RCA Occluded 1st Generation DES

Rotablation and Cutting Balloon to Release Stuck Externalized RG3 in an Ostial RCA Occluded 1st Generation DES

10 min.

Drug-Eluting Balloon Angioplasty in Chronic Total Occlusions to Improve the Distal Vessel

Drug-Eluting Balloon Angioplasty in Chronic Total Occlusions to Improve the Distal Vessel

5 min.

This website uses cookies to ensure you get the best experience on our website. Read More